Neuromuscular dysfunction in type 2 diabetes: Underlying mechanisms and effect of resistance training

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue 1, 2016, Pages 40-50

  Orlando, Giorgio ^a   Balducci, Stefano ^b,c   Bazzucchi, Ilenia ^a   Pugliese, Giuseppe ^b   Sacchetti, Massimo ^a  

^a UNIVERSITY OF ROME FORO ITALICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Metabolic Fitness Association   (Italy)

Author keywords

Diabetic neuropathy; Muscle endurance; Muscle strength; Resistance exercise; Type 2 diabetes

Indexed keywords

DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC PATIENT; HIGH RISK PATIENT; HUMAN; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; NERVE CONDUCTION; NEUROMUSCULAR DISEASE; NEUROMUSCULAR FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PHYSICAL DISABILITY; PRIORITY JOURNAL; RESISTANCE TRAINING; REVIEW; ANIMAL; BIOLOGICAL MODEL; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ENDURANCE; EVIDENCE BASED MEDICINE; INNERVATION; METABOLISM; NEUROMUSCULAR DISEASES; PATHOPHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; EVIDENCE-BASED MEDICINE; HUMANS; MODELS, NEUROLOGICAL; MUSCLE STRENGTH; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; PHYSICAL ENDURANCE; RESISTANCE TRAINING;

EID: 84953836732     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2658     Document Type: Review

References (98)

1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103(2): 137-149. doi:10.1016/j.diabres.2013.11.002.
2. Gregg EW, Beckles GL, Williamson DF, et al. Diabetes and physical disability among older U.S. adults. Diabetes Care 2000; 23(9): 1272-1277.
3. Maurer MS, Burcham J, Cheng H. Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. J Gerontol A Biol Sci Med Sci 2005; 60(9): 1157-1162.
4. Strotmeyer ESCJ. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med 2005; 165(14): 1612-1617.
5. Koproski J, Pretto Z, Poretsky L. Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care 1997; 20(10): 1553-1555.
6. Mayer-Davis EJ, Bell RA, Dabelea D, et al. Marcovina S; The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study. Diabetes Care 2009; 32(2): S99-S101. doi:10.2337/dc09-S201.
7. Sénéchal M, McGavock JM, Church TS, et al. Cut points of muscle strength associated with metabolic syndrome in men. Med Sci Sports Exerc 2014; 46(6): 1475-1481. doi:10.1249/MSS.0000000000000266.
8. Kalyani RR, Metter EJ, Egan J, Golden SH, Ferrucci L. Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care 2015; 38(1): 82-90. doi:10.2337/dc14-1166.
9. Sacchetti M, Balducci S, Bazzucchi I, et al. Neuromuscular dysfunction in diabetes: role of motor nerve impairment and training status. Med Sci Sports Exerc 2013; 45(1): 52-59. doi:10.1249/MSS.0b013e318269f9bb.
10. Colberg SR, Sigal RJ, Fernhall B, et al. American College of Sports Medicine; American Diabetes Association. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care 2010; 33(12): 147-167. doi:10.2337/dc10-9990.
11. Sigal RJ, Kenny GP, Boule' NG, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 2007; 147(6): 357-369.
12. Church TS, Blair SN, Cocreham S, et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA 2010; 304(20): 2253-2262. doi:10.1001/jama.2010.1710.
13. Balducci S, Zanuso S, Nicolucci A, et al. Italian Diabetes Exercise Study (IDES) Investigators. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). Arch Intern Med 2010; 170(20): 1794-1803. doi:10.1001/archinternmed.2010.380.
14. Larose J, Sigal RJ, Boulé NG, et al. Effect of exercise training on physical fitness in type II diabetes mellitus. Med Sci Sports Exerc 2010; 42(8): 1439-1447. doi:10.1249/MSS.0b013e3181d322dd.
15. Castaneda C, Layne JE, Munoz-Orians L, et al. A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care 2002; 25(12): 2335-2341.
16. Ibáñez J, Gorostiaga EM, Alonso AM, et al. Lower muscle strength gains in older men with type 2 diabetes after resistance training. J Diabetes Complications 2008; 22(2): 112-118. doi:10.1016/j.jdiacomp.2007.06.008.
17. Balducci S, Zanuso S, Cardelli P, et al. For the Italian Diabetes Exercise Study (IDES) Investigators. Changes in physical fitness predict improvements in modifiable cardiovascular risk factors independently of body weight loss in subjects with type 2 diabetes participating in the Italian Diabetes and Exercise Study (IDES). Diabetes Care 2012; 35(6): 1347-1354. doi:10.2337/dc11-1859.
18. Leenders M, Verdijk LB, van der Hoeven L, et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc 2013; 14(8): 585-592. doi:10.1016/j.jamda.2013.02.006.
19. Shah S, Sonawane P, Nahar P, Buge K, Vaidya S. Are we ignoring diabetic disability: a cross sectional study of diabetic myopathy. Indian J Med Sci 2011; 65(5): 186-192. doi:10.4103/0019-5359.106609.
20. Park SW, Goodpaster BH, Strotmeyer ES, et al. Decreased muscle strength and quality in older adults with type 2 diabetes. The Health, Aging, and Body Composition Study. Diabetes 2006; 55(6): 1813-1818.
21. Cetinus E, Buyukbese MA, Uzel M, Ekerbicer H, Karaoguz A. Handgrip strength in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2005; 70(3): 278-286.
22. Sayer AA, Dennison EM, Syddall H, Gilbody HJ, Phillips DI, Cooper C. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care 2005; 28(10): 2541-2542.
23. Ozdirenç M, Biberoğlu S, Ozcan A. Evaluation of physical fitness in patients with Type 2 diabetes mellitus. Diabetes Res Clin Pract 2003; 60(3): 171-176.
24. Volpato S, Bianchi L, Lauretani F, et al. Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes Care 2012; 35(8): 1672-1679. doi:10.2337/dc11-2202.
25. Kalyani RR, Tra Y, Yeh HC, Egan JM, Ferrucci L, Brancati FL. Quadriceps strength, quadriceps power, and gait speed in older U.S. adults with diabetes mellitus: results from the National Health and Nutrition Examination Survey, 1999-2002. J Am Geriatr Soc 2013; 61(5): 769-775. doi:10.1111/jgs.12204.
26. Park SW, Goodpaster BH, Strotmeyer ES, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the Health, Aging, and Body Composition study. Diabetes Care 2007; 30(6): 1507-1512.
27. Ijzerman TH, Schaper NC, Melai T, Meijer K, Willems PJ, Savelberg HH. Lower extremity muscle strength is reduced in people with type 2 diabetes, with and without polyneuropathy, and is associated with impaired mobility and reduced quality of life. Diabetes Res Clin Pract 2012; 95(3): 345-351. doi:10.1016/j.diabres.2011.10.026.
28. Hatef B, Bahrpeyma F, Mohajeri T. The comparison of muscle strength and short-term endurance in the different periods of type 2 diabetes. J Diabetes Metab Disord 2014; 3(1): 22. doi:10.1186/2251-6581-13-22.
29. Ijzerman TH, Schaper NC, Melai T, Blijham P, Meijer K, Willems PJ, Savelberg HH. Motor nerve decline does not underlie muscle weakness in type 2 diabetic neuropathy. Muscle Nerve 2011; 44(2): 241-245. doi:10.1002/mus.22039.
30. Sacchetti M, Olsen DB, Saltin B, van Hall G. Heterogeneity in limb fatty acid kinetics in type 2 diabetes. Diabetologia 2005; 48(5): 938-945.
31. Olsen DB, Sacchetti M, Dela F, Ploug T, Saltin B. Glucose clearance is higher in arm than leg muscle in type 2 diabetes. J Physiol 2005; 565(Pt2): 555-562.
32. Kim TN, Park MS, Yang SJ, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 2010; 33(7): 1497-1499. doi:10.2337/dc09-2310.
33. Morley JE. Diabetes, sarcopenia, and frailty. Clin Geriatr Med 2008; 24(3): 455-469. doi:10.1016/j.cger.2008.03.004.
34. Park SW, Goodpaster BH, Lee JS, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 2009; 32(11): 1993-1997. doi:10.2337/dc09-0264.
35. Fritschi C, Quinn L. Fatigue in patients with diabetes: a review. J Psychosom Res 2010; 69(1): 33-41. doi:10.1016/j.jpsychores.2010.01.021.
36. Halvatsiotis P, Short KR, Bigelow M, Nair KS. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 2002; 51(8): 2395-2404.
37. Allen MD, Kimpinski K, Doherty TJ, Rice CL. Decreased muscle endurance associated with diabetic neuropathy may be attributed partially to neuromuscular transmission failure. J Appl Physiol. 2015; 00441.2014. DOI: 10.1152/japplphysiol.00441.2014 [Epub ahead of print].
38. Almeida S, Riddell MC, Cafarelli E. Slower conduction velocity and motor unit discharge frequency are associated with muscle fatigue during isometric exercise in type 1 diabetes mellitus. Muscle Nerve 2008; 37(2): 231-240.
39. Andersen H. Muscular endurance in long-term IDDM patients. Diabetes Care 1998; 21(4): 604-609.
40. Oberbach A, Bossenz Y, Lehmann S, et al. Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care 2006; 29(4): 895-900.
41. Stuart CA, McCurry MP, Marino A, et al. Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness. J Clin Endocrinol Metab 2013; 98(5): 2027-2036. doi:10.1210/jc.2012-3876.
42. Segerström ÅB, Elgzyri T, Eriksson KF, Groop L, Thorsson O, Wollmer P. Exercise capacity in relation to body fat distribution and muscle fibre distribution in elderly male subjects with impaired glucose tolerance, type 2 diabetes and matched controls. Diabetes Res Clin Pract 2011; 94(1): 57-63. doi:10.1016/j.diabres.2011.05.022.
43. Mogensen M, Sahlin K, Fernström M, et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007; 56(6): 1592-1599.
44. Gaster M, Staehr P, Beck-Nielsen H, Schrøder HD, Handberg A. GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes 2001; 50(6): 1324-1329.
45. Hickey MS, Carey JO, Azevedo JL, et al. Skeletal muscle fiber compositionis related to adiposity and in vitro glucose transport rate in humans. Am J Physiol Endocrinol Metab 1995; 268(3 Pt 1): E453-E457.
46. Mårin P, Andersson B, Krotkiewski M, Björntorp P. Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 1994; 17(5): 382-386.
47. Rabøl R, Larsen S, Højberg PM, et al. Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesity. J Clin Endocrinol Metab 2010; 95(2): 857-863. doi:10.1210/jc.2009-1844.
48. He J, Watkins S, Kelley DE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001; 50(4): 817-823.
49. Andreassen CS, Jensen JM, Jakobsen J, Ulhøj BP, Andersen H. Striated muscle fiber size, composition, and capillary density in diabetes in relation to neuropathy and muscle strength. J Diabetes 2014; 6(5): 462-471. doi:10.1111/1753-0407.12124.
50. Van Loon LJ, Koopman R, Manders R, van der Weegen W, van Kranenburg GP, Keizer HA. Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am J Physiol Endocrinol Metab 2004; 287(3): E558-E565.
51. Cederholm T, Sylven C, Esbjornsson-Liljedahl M, Jansson E. Insulin treatment increases skeletal muscle fibre area in patients with diabetes mellitus type 2. ClinPhysiol 2000; 20(5): 354-359.
52. Zierath JR, He L, Guma A, Odegaard Wahlstrom E, Klip A, Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 in skeletal muscle from patients with NIDDM. Diabetologia 1996; 39(10): 1180-1189.
53. Coen PM, Dubé JJ, Amati F, et al. Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 2010; 59(1): 80-88. doi:10.2337/db09-0988.
54. Toft I, Bønaa KH, Lindal S, Jenssen T. Insulin kinetics, insulin action, and muscle morphology in lean or slightly overweight persons with impaired glucose tolerance. Metabolism 1998; 47(7): 848-854.
55. Nyholm B, Qu Z, Kaal A, et al. Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes 1997; 46(11): 1822-1828.
56. Chomentowski P, Coen PM, Radiková Z, Goodpaster BH, Toledo FG. Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J Clin Endocrinol Metab 2011; 96(2): 494-503. doi:10.1210/jc.2010-0822.
57. Solomon TP, Haus JM, Li Y. Kirwan JP Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability. J Clin Endocrinol Metab 2011; 96(5): 1377-1384. doi:10.1210/jc.2010-2069.
58. Schofield KL, Rehrer NJ, Perry TL, Ross A, Andersen JL, Osborne H. Insulin and fiber type in the offspring of T2DM subjects with resistance training and detraining. Med Sci Sports Exerc 2012; 44(12): 2331-2339. doi:10.1249/MSS.0b013e318268008f.
59. Dolan NC, Liu K, Criqui MH, et al. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 2002; 25(1): 113-120.
60. Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28(4): 956-962.
61. Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen H. Accelerated atrophy of lower leg and foot muscles - a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI). Diabetologia 2009; 52(6): 1182-1191. doi:10.1007/s00125-009-1320-0.
62. Andersen H, Nielsen S, Mogensem CE, Jakobsen J. Muscle strength in type 2 diabetes. Diabetes 2004; 53(6): 1543-1548.
63. Andersen H, Poulsen PL, Mogensen CE, Jakobsen J. Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications. Diabetes 1996; 45(4): 440-445.
64. Allen MD, Choi IH, Kimpinski K, Doherty TJ, Rice CL. Motor unit loss and weakness in association with diabetic neuropathy in humans. Muscle Nerve 2013; 48(2): 298-300. doi:10.1002/mus.23792.
65. Andreassen CS, Jakobsen J, Andersen H. Muscle weakness. A progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes 2006; 55(3): 806-812.
66. Balducci S, Sacchetti M, Orlando G, et al. Correlates of muscle strength in diabetes: the study on the assessment of determinants of muscle and bone strength abnormalities in diabetes (SAMBA). Nutr Metab Cardiovasc Dis 2014; 24(1): 18-26. doi:10.1016/j.numecd.2013.04.010.
67. Andersen H, Gadeberg PC, Brock B, Jakobsen J. Muscular atrophy in diabetic neuropathy. A stereological MR imaging study. Diabetologia 1997; 40(9): 1062-1069.
68. Orlov S, Bril V, Orszag A, Perkins BA. Heart rate variability and sensorimotor polyneuropathy in type 1 diabetes. Diabetes Care 2012; 35(4): 809-816. doi:10.2337/dc11-1652.
69. Petrofsky J, Prowse M, Remigio W, et al. The use of an isometric handgrip test to show autonomic damage in people with diabetes. Diabetes Technol Ther 2009; 11(6): 361-368. doi:10.1089/dia.2008.0094.
70. Landi F, Onder G, Bernabei R. Sarcopenia and diabetes: two sides of the same coin. J Am Med Dir Assoc 2013; 14(8): 540-541. doi:10.1016/j.jamda.2013.05.004.
71. Marzetti E, Lees HA, Manini TM, et al. Skeletal muscle apoptotic signaling predicts thigh muscle volume and gait speed in community-dwelling older persons: an exploratory study. PLoS One 2012; 7(2): 328-329. doi:10.1371/journal.pone.0032829.
72. Roatta S, Passatore M. Autonomic effects on skeletal muscle. In Encyclopedia of Neuroscience, Binder MD, Hirokawa N, Windhorst U (eds). Springer: Berlin-Heidelberg-New York., 2009; 250-253.
73. Frontera WR, Reid KF, Phillips EM, et al. Muscle fiber size and function in elderly humans: a longitudinal study. J Appl Physiol 2008; 105(2): 637-642. doi:10.1152/japplphysiol.90332.2008.
74. Bottinelli R, Reggiani C. Human skeletal muscle fibres: molecular and functional diversity. Prog Biophys Mol Biol 2000; 73(2-4): 195-262.
75. Stephenson GMM, O'Callaghan A, Stephenson DG. Single-fiber study of contractile and biochemical properties of skeletal muscles in streptozotocin-induced diabetic rats. Diabetes 1994; 43(5): 622-628.
76. Challiss RAJ, Vranick M, Radda GK. Bioenergetic changes during contraction and recovery in diabetic rat skeletal muscle. Am J Physiol Endocrinol Metab 1989; 256(Pt 1): E129-E137.
77. Challiss RAJ, Blackledge MJ, Radda GK. Spatially resolved changes in diabetic rat skeletal muscle metabolism in vivo studied by 31p-n.m.r. spectroscopy. Biochem J 1990; 268(1): 111-115.
78. Cotter M, Cameron NE, Lean DR, Robertson S. Effects of long-term streptozotocin diabetes on the contractile and histochemical properties of rat muscles. Q J Exp Physiol 1989; 74(1): 65-74.
79. Cameron NE, Cotter MA, Robertson S. Changes in skeletal muscle contractile properties in streptozotocin-induced diabetic rats and role of polyolpathway and hypoinsulinemia. Diabetes 1990; 39(4): 460-465.
80. Fahim F, El-Sabban F, Davidson N. Muscle contractility decrement and correlated morphology during the pathogenesis of streptozotocin-diabetic mice. Anat Rec 1998; 251(2): 240-244.
81. Ramamurthy B, Höök P, Jones AD, Larsson L. Changes in myosin structure and function in response to glycation. FASEB J 2001; 15(13): 2415-2422.
82. Moore RD, Munford JW, Pillsworth TJ Jr. Effects of streptozotocin diabetes and fasting on intracellular sodium and adenosine triphosphate in rat soleus muscle. J Physiol 1983; 338: 277-294.
83. Kimura M, Kimura I, Nakamura T, Nojima H. Diabetic state-induced modification of resting membrane potential and conductance in diaphragm muscle of alloxan and diabetic KK-CAy mice. Diabetologia 1988; 31(2): 103-107.
84. Simoneau JA, Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 1997; 83(1): 166-171.
85. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51(10): 2944-2950.
86. Kelley DE, Simoneau JA. Impaired free fatty acid utilization by skeletal muscle in non-insulin dependent diabetes mellitus. J Clin Invest 1994; 94(6): 2349-2356.
87. Ritov VB, Menshikova EV, Azuma K, et al. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab 2010; 298(1): E49-E58. doi:10.1152/ajpendo.00317.2009.
88. Holmang A, Brzezinska Z, Bjorntorp P. Effect of hyperinsulinemia of muscle fiber composition and capillarization in rats. Diabetes 1993; 42(7): 1073-1081.
89. Houmard JA, O'Neill DS, Zheng D, Hickey MS, Dohm GL. Impact of hyperinsulinemia on myosin heavy chain gene regulation. J Appl Physiol 1999; 86(6): 1828-1832.
90. Mann S, Beedie C, Balducci S, et al. Changes in insulin sensitivity in response to different modalities of exercise: a review of the evidence. Diabetes Metab Res Rev 2014; 30(4): 257-268. doi:10.1002/dmrr.2488.
91. Ibanez J, Izquierdo M, Arguelles I, et al. Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes Care 2005; 28(3): 662-667.
92. Eriksson J, Taimela S, Eriksson K, Parviainen S, Peltonen J, Kujala U. Resistance training in the treatment of non-insulin-dependent diabetes mellitus. Int J Sports Med 1997; 18(4): 242-246.
93. Dunstan DW, Daly RM, Owen N. High intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabetes Care 2002; 25(10): 1729-1736.
94. Kwon HR, Han KA, Ku YH, Ahn HJ, Koo BK, Kim HC, Min KW. The effects of resistance training on muscle and body fat mass and muscle strength in type 2 diabetic women. Korean Diabetes J 2010; 34(2): 101-110. doi:10.4093/kdj.2010.34.2.101.
95. Ishii T, Yamakita T, Sato T, Tanaka S, Fujii S. Resistance training improves insulin sensitivity in NIDDM subjects without altering maximal oxygen uptake. Diabetes Care 1998; 21(8): 1353-1355.
96. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F. Strength training increases insulin mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004; 53(2): 294-305.
97. Brooks N, Layne JE, Gordon PL. Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes. Int J Med Sci 2006; 4(1): 19-27.
98. Mavros Y, Kay S, Anderberg KA, et al. Changes in insulin resistance and HbA1c are related to exercise-mediated changes in body composition in older adults with type 2 diabetes: interim outcomes from the GREAT2DO trial. Diabetes Care 2013; 36(8): 2372-1379. doi:10.2337/dc12-2196.